neskid_c14_EKDL220008460-1A_HTLHVDSX3_L3_1.fq
Laetitia Koppe, Alice Beau · Recherche Data Gouv France · 2024
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Recherche Data Gouv France · OpenAlex · dataset · 2024
Abstract
Metagenomic data of the intestinal microbiota were collected from mice with and without kidney disease, with or without synbiotic treatment. Chronic Kidney Disease (CKD) is characterized by accumulation of uremic toxins (UTs), such as p-cresyl sulfate and indoxyl sulfate, generated through the transformation of tyrosine and tryptophan by the gut microbiota. We further designed a novel specific synbiotic for CKD (SynCKD) that are able to decrease UTs in silico and in vitro. We tested a specific synbiotic (SynCKD) in a male mouse model of CKD induced by two-step 5/6 nephrectomy at 6 weeks of age. The mice were treated with either a placebo or the synbiotic for 6 weeks.
Fecal samples were collected at the end of the treatment period for analysis. The in vivo efficacy of SynCKD was demonstrated by reduced plasma levels of uremic toxins (UTs) and improved kidney function after 6 tweeks of treatment. Finally, metagenomic analyses showed that SynCKD resulted in a lower abundance of microbial genes involved in tryptophan and tyrosine degradation.
Open the resolved locator · 10.57745/dkgoeb
Metadata licence: OpenAlex metadata (CC0)